Key result
HF cardiogenic shock requires shifting from blood pressure definitions to an integrated haemometabolic framework.
Why the study?
Although heart failure-related cardiogenic shock is now the predominant aetiology of cardiogenic shock, contemporary diagnostic and therapeutic frameworks remain largely extrapolated from acute myocardial infarction-related cardiogenic shock despite fundamental differences in pathophysiology and clinical trajectories.
Heart failure-related cardiogenic shock requires shifting from blood pressure-centric definitions derived from acute myocardial infarction to a comprehensive haemometabolic framework integrating congestion, perfusion, and metabolic status alongside early multidisciplinary shock team intervention.
Answers are grounded in this paper and cite their sources.
Challenges BP-centric criteria in HF shock; hypothesis-generating for HF-specific SCAI refinement pending validation.
Cardiogenic shock (CS) is increasingly recognised as a heterogeneous syndrome, with heart failure-related cardiogenic shock (HF-CS) now representing the predominant aetiology. However, contemporary diagnostic and therapeutic frameworks remain largely extrapolated from acute myocardial infarction-related cardiogenic shock (AMI-CS), despite fundamental differences in pathophysiology and clinical trajectories. In HF-CS, pathophysiology is better conceptualised as a haemometabolic construct in which congestion, impaired forward flow, and systemic metabolic dysfunction interact to drive progressive multiorgan failure. These processes are often poorly captured by conventional blood pressure (BP)–based definitions of CS, particularly in heart failure, where patients may have persistently low yet compensated baseline BP. Although the Society of Cardiovascular and Angiographic Interventions shock classification provides a useful severity-based framework, emerging evidence supports a more integrated diagnostic approach that incorporates biomarkers such as lactate, mixed venous oxygen saturation, and invasive haemodynamic profiling. Together, these measures may improve risk stratification and better guide the timing and selection of escalation strategies. In parallel, multidisciplinary shock team models may improve outcomes in HF-CS, particularly when implemented early, before irreversible end-organ dysfunction develops. Future advances in HF-CS will require a shift away from BP-centric definitions derived from AMI-CS towards a comprehensive haemometabolic framework integrating congestion, perfusion, and haemometabolic status. Prospective HF-CS specific trials evaluating early, phenotype-guided care within structured, protocol-driven systems are essential to improving outcomes in this growing and clinically complex population.
No takes yet. Share an insight, caveat, or question.
Eng‐Frost et al. (2026) conducted a review in Heart failure-related cardiogenic shock (HF-CS). Integrated haemometabolic diagnostic and multidisciplinary shock team approach vs. Conventional blood pressure-centric definitions derived from AMI-CS was evaluated. Heart failure-related cardiogenic shock requires shifting from blood pressure-centric definitions to a haemometabolic framework integrating biomarkers, invasive profiling, and shock teams.
Synapse has enriched 10 related papers. Consider them for comparative context: